|Jmol-3D images||Image 1|
|Molar mass||212.32 g/mol|
|Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)|
Burimamide was first developed by scientists at Smith, Kline & French (SK&F; now GlaxoSmithKline) in their intent to develop a histamine antagonist for the treatment of peptic ulcers. The discovery of buriamide ultimately led to the development of cimetidine (Tagamet).
- -receptor Antagonists"2: Discovery of Histamine H®"Tagamet. National Historic Chemical Landmarks. American Chemical Society. Retrieved June 25, 2012.